Cibus Appoints Co-Founder Rory Riggs as Chief Executive Officer
Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer
Cibus Opens Gene Editing Facility for Trait Production
Margaret Crotty and Rory Riggs Health Care Leadership Award, 2024
Royalty Pharma Co-Founder Writes Open Letter to Board of Elan Ahead of EGM
Syntax LLC Announces Launch of Stratified LargeCap ESG Index
Inventor of the coordinate-based Locus Model and Functional Information System for classifying economic activity by function rather than conventional industry category.
Built the Syntax Stratified Indices, benchmark indices constructed on functional rather than conventional sector classification.
Index construction and portfolio classification
Managing Director in M&A at PaineWebber, 1981–1990.
Founded and built Royalty Pharma into the world's largest acquirer of pharmaceutical royalties, helping create the category as an investable asset class.
Led Cibus's application of production-system methodology to plant biology through the Rapid Trait Development System.
Precision gene editing / agricultural biotechnology
Managing Member of Balfour Venture Partners.
President, CFO, and Director of BioMatrix, overseeing the launch of Synvisc, a viscosupplementation treatment.
President, CFO, and Director at BioMatrix Inc.
Transitioned from Chief Executive Officer to Chairman of the Board in June 2026 as Craig Wichner became CEO.
Co-founder and CEO of Cibus, the leading precision gene-editing company for agriculture. Applied the Locus Model's functional-systems approach to plant biology through the Rapid Trait Development System (RTDS).
Chair of eReceivables, a healthcare service technology company.
Managing Director in the mergers and acquisitions group at PaineWebber.
Managing Director, Mergers & Acquisitions
Managing Director, Mergers & Acquisitions at PaineWebber Inc.
CEO of RF&P, a real estate investment company owned by the Virginia State Retirement System.
Chief Executive Officer at RF&P Corporation
Co-founded Royalty Pharma in 1996 with a $60 million start; built it into the world's largest acquirer of pharmaceutical royalties, holding partial royalty rights on seven of the top thirty drugs sold in the United States. Served as Chairman from 2003 and resigned as a director on June 6, 2024.
Chairman and Founder at Royalty Pharma plc
General Partner and co-founder of Scientia Ventures.
Founded Locus Analytics in 2009 as an economic research firm to pioneer Systems Economics and develop and patent the Functional Information System. Syntax and Locus Analytics merged in March 2023. Built the coordinate-based Locus Model and FIS information infrastructure for finance and economic data, and the Syntax Stratified Indices.
Executive Chairman / Founder at Syntax Data (Syntax LLC / Locus Analytics)
CEO and Trustee of the Syntax-affiliated ETF trust since 2017.
CEO and Trustee at WEBS ETF Trust (Syntax ETF Trust)
Angel investor and board member of the fintech company Bond Street Marketplace.
Director of the Feinstein Institute, the research arm of Northwell Health.
Co-founder and director of FibroGen since October 1993 — his longest confirmed board tenure.
Board Chair and director of GeneNews, later StageZero Life Sciences, since 1998.
Director of Intra-Cellular Therapies from January 2014, serving on the Audit Committee.
Director of the New York Genome Center, his primary current nonprofit board.
Syntax Data (Syntax LLC / Locus Analytics)
Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics. Mr. Riggs is Executive Chairman of Syntax Data, which has built a foundational coordinate-based information infrastructure for finance and economic data based on his patented Locus Model and Functional Information System (FIS).
Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics.
President, CFO, and Director, 1996–2000; oversaw the launch of Synvisc.
Co-founder; CEO 2021–2026, then Chairman of the Board.
Current director of the research arm of Northwell Health.
Co-founder and director since October 1993.
Managing Director, Mergers & Acquisitions, 1981–1990.
CEO, 1991–1995, a Virginia State Retirement System–owned real estate investment company.
Co-founder and Chairman (2003–2024); built the pharmaceutical royalty asset class.
Founder and Executive Chairman; built the Locus Model, Functional Information System, and Syntax Stratified Indices.
The personal site of Rory Riggs — inventor of the Locus Model and Functional Coordinates, founder of Systems Economics, and Executive Chairman of Syntax Data. Documents his work across financial classification (FIS, Syntax Stratified Indices), agricultural biotechnology (Cibus, Rapid Trait Development System), and pharmaceutical royalties (Royalty Pharma).